首页 > 最新文献

Medical alphabet最新文献

英文 中文
Intestinal microbiota and gallstone disease – is there a connection? 肠道微生物群与胆石症--有联系吗?
Pub Date : 2024-05-07 DOI: 10.33667/2078-5631-2024-5-23-26
V. Akhmedov
Cholelithiasis is a fairly common disease of the digestive system, affecting from 10 % to 15 % of the adult population. Despite many studies devoted to this problem, the mechanisms of formation of gallstone disease have not been fully elucidated. Recently, aspects of the influence of the intestinal microbiota on the mechanisms of formation of various pathologies of the gastrointestinal tract such as non-alcoholic fatty liver disease, inflammatory bowel diseases, irritable bowel syndrome, pancreatic diseases, gastroesophageal reflux disease have been considered. The presented review article examines the possible involvement of the gastrointestinal microbiome in the pathogenesis of gallstone disease. The article discusses the role of microorganisms and their metabolites in the formation of gallstones.
胆石症是一种相当常见的消化系统疾病,影响着 10 % 到 15 % 的成年人。尽管对这一问题进行了大量研究,但胆石症的形成机制尚未完全阐明。最近,人们开始考虑肠道微生物群对胃肠道各种病症(如非酒精性脂肪肝、炎症性肠病、肠易激综合征、胰腺疾病、胃食管反流病)形成机制的影响。这篇综述文章探讨了胃肠道微生物组可能参与胆石症发病机制的问题。文章讨论了微生物及其代谢产物在胆结石形成过程中的作用。
{"title":"Intestinal microbiota and gallstone disease – is there a connection?","authors":"V. Akhmedov","doi":"10.33667/2078-5631-2024-5-23-26","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-5-23-26","url":null,"abstract":"Cholelithiasis is a fairly common disease of the digestive system, affecting from 10 % to 15 % of the adult population. Despite many studies devoted to this problem, the mechanisms of formation of gallstone disease have not been fully elucidated. Recently, aspects of the influence of the intestinal microbiota on the mechanisms of formation of various pathologies of the gastrointestinal tract such as non-alcoholic fatty liver disease, inflammatory bowel diseases, irritable bowel syndrome, pancreatic diseases, gastroesophageal reflux disease have been considered. The presented review article examines the possible involvement of the gastrointestinal microbiome in the pathogenesis of gallstone disease. The article discusses the role of microorganisms and their metabolites in the formation of gallstones.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141002957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the content of short-chain fatty acids in ulcerative colitis as an indicator of the patient's metabolic health 评估溃疡性结肠炎患者体内短链脂肪酸的含量,作为衡量患者代谢健康状况的指标
Pub Date : 2024-05-07 DOI: 10.33667/2078-5631-2024-5-27-31
G. Bikbavova, M. A. Livzan, N. S. Lisyutenko, A. E. Romanyuk, A. V. Indutny, O. V. Martynenko
Numerous studies show that in the pathogenesis of ulcerative colitis (UC), a significant role is played by a change in the diversity of the intestinal microflora, which is associated with fewer bacteria producing short-chain fatty acids (SCFAs). SCFCS affect the differentiation and activation of cells of the immune system, play a protective role in maintaining the integrity of the epithelial barrier, participate in the regulation of intestinal peristalsis and blood supply to its wall, muscle anabolism, bioavailability of amino acids.The aim of the study. To evaluate the content of SCLC in the feces of UC patients with varying degrees of severity of the current attack, as well as to investigate the relationship between the content of SCLC with dietary characteristics, body mass index (BMI), and dyspenia.Materials and methods. The study involved 80 UC patients, conducted a survey, objective examination, filling out medical history and outpatient records, blood and stool sampling. The content of SCLC was determined in feces. The study of nutritional characteristics in patients with UC was conducted using a standardized questionnaire of the WHO CINDI program. Statistical methods: median (Me), upper and lower quartiles (P25, P75) were calculated; Mann-Whitney criterion; Kolmogorov-Smirnov criterion; nonparametric correlation analysis was performed.Results. The absolute content of SCFCS in the feces of patients with UC is lower than the reference values. The relative content of propionic acid in the subgroup with severe attack was significantly lower than in the remission subgroup, in the subgroup with mild and moderate attack of the disease. In patients with body weight deficiency, the relative content of propionic acid is lower than in UC patients with normal or overweight. A positive relationship was found between the total content of SCFCS in feces and the amount of dietary fiber consumed in the form of fruits and vegetables. In patients with dinapenia, the relative content of butyric acid in feces is significantly lower than in patients without dinapenia.
大量研究表明,在溃疡性结肠炎(UC)的发病机制中,肠道微生物区系多样性的变化起着重要作用,这与产生短链脂肪酸(SCFA)的细菌数量减少有关。SCFCS 影响免疫系统细胞的分化和活化,在维持上皮屏障的完整性方面发挥保护作用,参与调节肠道蠕动和肠壁供血、肌肉合成代谢、氨基酸的生物利用率。评估目前发作程度不同的 UC 患者粪便中 SCLC 的含量,并研究 SCLC 含量与饮食特点、体重指数(BMI)和消化不良之间的关系。研究涉及 80 名 UC 患者,通过调查、客观检查、填写病史和门诊记录、抽血和大便等方式进行。测定粪便中 SCLC 的含量。使用世界卫生组织 CINDI 计划的标准化问卷对 UC 患者的营养特征进行了研究。统计方法:计算中位数(Me)、上下四分位数(P25、P75);Mann-Whitney标准;Kolmogorov-Smirnov标准;非参数相关分析。UC患者粪便中SCFCS的绝对含量低于参考值。重度发作亚组的丙酸相对含量明显低于缓解亚组、轻度和中度发作亚组。在体重不足的患者中,丙酸的相对含量低于体重正常或超重的 UC 患者。研究发现,粪便中 SCFCS 的总含量与水果和蔬菜中膳食纤维的摄入量呈正相关。患有二钠潴留症的患者粪便中丁酸的相对含量明显低于未患二钠潴留症的患者。
{"title":"Assessment of the content of short-chain fatty acids in ulcerative colitis as an indicator of the patient's metabolic health","authors":"G. Bikbavova, M. A. Livzan, N. S. Lisyutenko, A. E. Romanyuk, A. V. Indutny, O. V. Martynenko","doi":"10.33667/2078-5631-2024-5-27-31","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-5-27-31","url":null,"abstract":"Numerous studies show that in the pathogenesis of ulcerative colitis (UC), a significant role is played by a change in the diversity of the intestinal microflora, which is associated with fewer bacteria producing short-chain fatty acids (SCFAs). SCFCS affect the differentiation and activation of cells of the immune system, play a protective role in maintaining the integrity of the epithelial barrier, participate in the regulation of intestinal peristalsis and blood supply to its wall, muscle anabolism, bioavailability of amino acids.The aim of the study. To evaluate the content of SCLC in the feces of UC patients with varying degrees of severity of the current attack, as well as to investigate the relationship between the content of SCLC with dietary characteristics, body mass index (BMI), and dyspenia.Materials and methods. The study involved 80 UC patients, conducted a survey, objective examination, filling out medical history and outpatient records, blood and stool sampling. The content of SCLC was determined in feces. The study of nutritional characteristics in patients with UC was conducted using a standardized questionnaire of the WHO CINDI program. Statistical methods: median (Me), upper and lower quartiles (P25, P75) were calculated; Mann-Whitney criterion; Kolmogorov-Smirnov criterion; nonparametric correlation analysis was performed.Results. The absolute content of SCFCS in the feces of patients with UC is lower than the reference values. The relative content of propionic acid in the subgroup with severe attack was significantly lower than in the remission subgroup, in the subgroup with mild and moderate attack of the disease. In patients with body weight deficiency, the relative content of propionic acid is lower than in UC patients with normal or overweight. A positive relationship was found between the total content of SCFCS in feces and the amount of dietary fiber consumed in the form of fruits and vegetables. In patients with dinapenia, the relative content of butyric acid in feces is significantly lower than in patients without dinapenia.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141003472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical case of a continuous course of ulcerative with extra-intestinal manifestations 一个溃疡病持续病程并伴有肠外表现的临床病例
Pub Date : 2024-05-07 DOI: 10.33667/2078-5631-2024-5-13-17
G. Bikbavova, V. A. Livzan, V. Akhmedov, T. V. Tretyakova, V. A. Voyat, L. I. Telyatnikova
Ulcerative colitis (UC) is one of the most serious and poor-studied problems of modern gastroenterology. This nosology is a diffuse inflammation of the intestinal mucosa, limited to the colon with a predominant lesion of the rectum and sigmoid colon. Due to the progressive nature of the disease, patients require lifelong drug therapy and monitoring. Extra-intestinal manifestations are often found in patients with UC and represent a complex problem that requires the close attention of specialists and the appointment of modern pathogenetically-based treatment, including genetically engineered biological drugs. This clinical observation reflects the importance of early diagnosis of UC with extra-intestinal manifestations – primary sclerosing cholangitis and arthropathy, as well as the effectiveness of treatment with ustekinumab.
溃疡性结肠炎(UC)是现代肠胃病学中最严重、研究最不深入的问题之一。溃疡性结肠炎是一种肠粘膜弥漫性炎症,局限于结肠,以直肠和乙状结肠为主。由于该病具有进展性,患者需要终生接受药物治疗和监测。UC 患者经常会出现肠外表现,这是一个复杂的问题,需要专科医生密切关注,并采用基于病理的现代治疗方法,包括基因工程生物药物。这一临床观察结果反映了早期诊断伴有肠道外表现--原发性硬化性胆管炎和关节病--的 UC 的重要性,以及使用乌斯特库单抗治疗的有效性。
{"title":"A clinical case of a continuous course of ulcerative with extra-intestinal manifestations","authors":"G. Bikbavova, V. A. Livzan, V. Akhmedov, T. V. Tretyakova, V. A. Voyat, L. I. Telyatnikova","doi":"10.33667/2078-5631-2024-5-13-17","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-5-13-17","url":null,"abstract":"Ulcerative colitis (UC) is one of the most serious and poor-studied problems of modern gastroenterology. This nosology is a diffuse inflammation of the intestinal mucosa, limited to the colon with a predominant lesion of the rectum and sigmoid colon. Due to the progressive nature of the disease, patients require lifelong drug therapy and monitoring. Extra-intestinal manifestations are often found in patients with UC and represent a complex problem that requires the close attention of specialists and the appointment of modern pathogenetically-based treatment, including genetically engineered biological drugs. This clinical observation reflects the importance of early diagnosis of UC with extra-intestinal manifestations – primary sclerosing cholangitis and arthropathy, as well as the effectiveness of treatment with ustekinumab.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141003624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Side effects of proton pump inhibitors with long-term use: focus on the urinary system 长期使用质子泵抑制剂的副作用:关注泌尿系统
Pub Date : 2024-05-07 DOI: 10.33667/2078-5631-2024-5-36-42
D. Trukhan, I. Viktorova
Proton pump inhibitors (PPIs) are the most effective drugs for treating acid-related diseases. In recent decades, the use of PPIs has increased exponentially. For a long time, PPIs were considered completely safe drugs for both short-term and long-term use. However, modern clinical guidelines note that when prescribing PPIs in large doses for a long period, the possibility of side effects should be taken into account. In recent years, a number of foreign reviews have been published that examine the associations between PPIs and a number of diseases/conditions. We searched the PubMed and Scopus information databases for publications on the safety of PPI use, including sources up to January 30, 2024. In this review, we examined the effect of long-term use of PPIs on the urinary system. This review demonstrates possible changes in the urinary system and an increased risk of developing nephrolithiasis, acute interstitial nephritis, acute kidney injury, chronic kidney disease, end-stage renal failure with long-term use of PPIs, which should certainly be taken into account when prescribing them for a long period, especially in patients with comorbid pathology.
质子泵抑制剂(PPI)是治疗胃酸相关疾病的最有效药物。近几十年来,PPIs 的使用量成倍增加。长期以来,PPIs 被认为是短期和长期使用都完全安全的药物。然而,现代临床指南指出,在长期大剂量处方 PPIs 时,应考虑到副作用的可能性。近年来,国外发表了多篇综述,探讨了 PPI 与多种疾病/病症之间的关联。我们在 PubMed 和 Scopus 信息数据库中搜索了有关 PPI 使用安全性的出版物,包括截至 2024 年 1 月 30 日的资料来源。在这篇综述中,我们研究了长期服用 PPI 对泌尿系统的影响。本综述表明,长期使用 PPIs 可能会导致泌尿系统发生变化,并增加患肾炎、急性间质性肾炎、急性肾损伤、慢性肾病、终末期肾衰竭的风险。
{"title":"Side effects of proton pump inhibitors with long-term use: focus on the urinary system","authors":"D. Trukhan, I. Viktorova","doi":"10.33667/2078-5631-2024-5-36-42","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-5-36-42","url":null,"abstract":"Proton pump inhibitors (PPIs) are the most effective drugs for treating acid-related diseases. In recent decades, the use of PPIs has increased exponentially. For a long time, PPIs were considered completely safe drugs for both short-term and long-term use. However, modern clinical guidelines note that when prescribing PPIs in large doses for a long period, the possibility of side effects should be taken into account. In recent years, a number of foreign reviews have been published that examine the associations between PPIs and a number of diseases/conditions. We searched the PubMed and Scopus information databases for publications on the safety of PPI use, including sources up to January 30, 2024. In this review, we examined the effect of long-term use of PPIs on the urinary system. This review demonstrates possible changes in the urinary system and an increased risk of developing nephrolithiasis, acute interstitial nephritis, acute kidney injury, chronic kidney disease, end-stage renal failure with long-term use of PPIs, which should certainly be taken into account when prescribing them for a long period, especially in patients with comorbid pathology.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141002343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of mebeverine in extended-release capsules on intestinal motor function in patients with functional gastrointestinal pathology 美贝维林缓释胶囊对功能性胃肠病患者肠道运动功能的影响
Pub Date : 2024-05-07 DOI: 10.33667/2078-5631-2024-5-7-12
M. A. Butov, M. Msakni, V. M. Butova, N. A. Sudakova, I. Y. Vornacheva, L. I. Karpova
Purpose of the study. Evaluation of the clinical effectiveness of combination therapy for FGID with overlap syndrome – gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and irritable bowel syndrome (IBS) using the PPI omeprazole and the myotropic antispasmodic mebeverine hydrochloride in extended-release capsules (Meberin ML, Micro Labs Limited, India) on clinical manifestations and motor-evacuation function of the gastrointestinal tract in patients with FGID with overlap syndrome – GERD, FD with gastric hypersecretion and IBS.Materials and methods. We examined 27 patients with FGID with overlap syndrome of GERD, FD with gastric hypersecretion of hydrochloric acid and IBS.Results and conclusion. It has been established that combination therapy with these drugs for two weeks in 97 % of cases eliminates the clinical symptoms of the syndromes, improves the quality of life of patients, normalizes intestinal motility and myoelectric activity of the gastrointestinal tract.
研究目的评估使用 PPI 奥美拉唑和促肌解痉药盐酸甲贝维林缓释胶囊(Meberin ML. Micro Labs Limited, India)联合治疗 FGID 重叠综合征--胃食管反流病(GERD)、功能性消化不良(FD)和肠易激综合征(IBS)对 FGID 重叠综合征--胃食管反流病、功能性消化不良和肠易激综合征--患者的临床表现和胃肠道运动排空功能的临床疗效、印度 Micro Labs 有限公司)对伴有胃食管反流病、伴有胃分泌亢进的 FD 和肠易激综合征(IBS)重叠综合征的 FGID 患者的临床表现和胃肠道运动排空功能的影响。材料和方法我们对27名患有胃食管反流病、FD伴胃酸盐分泌过多和肠易激综合征重叠综合征的FGID患者进行了检查。经证实,在 97% 的病例中,使用这些药物进行为期两周的联合治疗可消除综合征的临床症状,改善患者的生活质量,使肠道运动和胃肠道肌电活动恢复正常。
{"title":"The effect of mebeverine in extended-release capsules on intestinal motor function in patients with functional gastrointestinal pathology","authors":"M. A. Butov, M. Msakni, V. M. Butova, N. A. Sudakova, I. Y. Vornacheva, L. I. Karpova","doi":"10.33667/2078-5631-2024-5-7-12","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-5-7-12","url":null,"abstract":"Purpose of the study. Evaluation of the clinical effectiveness of combination therapy for FGID with overlap syndrome – gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and irritable bowel syndrome (IBS) using the PPI omeprazole and the myotropic antispasmodic mebeverine hydrochloride in extended-release capsules (Meberin ML, Micro Labs Limited, India) on clinical manifestations and motor-evacuation function of the gastrointestinal tract in patients with FGID with overlap syndrome – GERD, FD with gastric hypersecretion and IBS.Materials and methods. We examined 27 patients with FGID with overlap syndrome of GERD, FD with gastric hypersecretion of hydrochloric acid and IBS.Results and conclusion. It has been established that combination therapy with these drugs for two weeks in 97 % of cases eliminates the clinical symptoms of the syndromes, improves the quality of life of patients, normalizes intestinal motility and myoelectric activity of the gastrointestinal tract.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141005710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulant prophylaxis in patients with liver disease and atrial fibrillation 肝病和心房颤动患者的抗凝剂预防措施
Pub Date : 2024-05-06 DOI: 10.33667/2078-5631-2024-3-17-22
A. Komarova, S. Bliznyuk, D. S. Lyasina, E. A. Naryshkina, A. V. Bumbu, S. Covantsev
Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults worldwide. The use of oral anticoagulants (DOACs) is an effective way to prevent ischemic stroke in patients with AF, reducing the risk of stroke by approximately 64 %. In patients with liver cirrhosis (LC), the presence of AF is associated with higher rates of in-hospital mortality, stroke and acute kidney injury compared with patients without arrhythmia. Liver disease and especially cirrhosis are associated with an increased risk of not only thrombosis but also bleeding, making the decision about anticoagulant therapy in these patients very difficult. The article reviews the current literature regarding the use of modern DOACs and traditional antithrombotic agents, such as vitamin K antagonists and heparins, in patients with cirrhosis and AF.
心房颤动(房颤)是全球成人中最常见的心律失常。使用口服抗凝剂(DOACs)是预防房颤患者缺血性中风的有效方法,可将中风风险降低约 64%。在肝硬化(LC)患者中,与无心律失常的患者相比,房颤的存在与较高的院内死亡率、中风和急性肾损伤相关。肝脏疾病,尤其是肝硬化不仅会增加血栓形成的风险,还会增加出血的风险,这使得这些患者很难做出抗凝治疗的决定。文章回顾了有关肝硬化和房颤患者使用现代 DOAC 和传统抗血栓药物(如维生素 K 拮抗剂和肝素)的现有文献。
{"title":"Anticoagulant prophylaxis in patients with liver disease and atrial fibrillation","authors":"A. Komarova, S. Bliznyuk, D. S. Lyasina, E. A. Naryshkina, A. V. Bumbu, S. Covantsev","doi":"10.33667/2078-5631-2024-3-17-22","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-3-17-22","url":null,"abstract":"Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults worldwide. The use of oral anticoagulants (DOACs) is an effective way to prevent ischemic stroke in patients with AF, reducing the risk of stroke by approximately 64 %. In patients with liver cirrhosis (LC), the presence of AF is associated with higher rates of in-hospital mortality, stroke and acute kidney injury compared with patients without arrhythmia. Liver disease and especially cirrhosis are associated with an increased risk of not only thrombosis but also bleeding, making the decision about anticoagulant therapy in these patients very difficult. The article reviews the current literature regarding the use of modern DOACs and traditional antithrombotic agents, such as vitamin K antagonists and heparins, in patients with cirrhosis and AF.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141006814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of invasive hemodynamics monitoring in sepsis intensive care 有创血液动力学监测在脓毒症重症监护中的作用
Pub Date : 2024-05-06 DOI: 10.33667/2078-5631-2024-3-23-28
I. A. Kozlov, A. Ovezov, S. A. Rautbart
The objective was to study the effect of early planned use of transpulmonary thermodilution (TPTD) and therapeutic measures to stabilize blood circulation on the clinical outcome of sepsis.Materials and methods. The cohort study involved 132 patients with abdominal sepsis with SOFA >7 and blood lactate >1.6 mmol/L. Septic shock was diagnosed in 56 % of patients. TPTD in the early periods of intensive care was began in 53.8 % of patients. Logistic regression and ROC-analysis were used to process the data.Results. Early use of invasive monitoring (OR 2,3715, 95 % CI 1,1107–5,0635, p=0,026, AUC 0.655) and infusion volume >43 ml/kg per day (OR 1.0313, 95 % CI 1.0073–1.0558, p=0.01, AUC 0.677) were predictors of survival in patients with abdominal sepsis. The use of TPTD compared to patients of group II was accompanied by an increase in the daily infusion volume (53.7 [38.1–63.5] vs 38.2 [29.9–47.2], ml/kg per day, p = 0.0001), more frequent use of inotropic drugs (39.4 vs 16.4 %, p = 0.004), and higher level of the inotropic scale (0 [0–4.7] vs 0 [0–0], p = 0.01). There were no differences in the frequency of prescription (57.7 vs 65.5 %, p = 0.376) and dosages (0.2 [0.1–0.4] vs 0.3 [0.2–0.4] μg/kg/min, p = 0.554) of norepinephrine. Twenty-eight-day mortality in groups I and II was 31 and 50.8 % (p = 0.022), hospital mortality was 32.9 and 54.0 % (p = 0.014).Conclusion. When assessed by SOFA > 7 points and lactatemia > 1.6 mmol/L, the onset of TPTD and infusion volume > 43 mL/kg/day increase the likelihood of survival of patients with abdominal sepsis, as a result, 28-day and hospital mortality decrease by 1.6 times. The use of invasive monitoring of central hemodynamics in this clinical situation is accompanied by an increase in the prescription of inotropes by 2.4 times with an unchanged intensity of norepinephrine use. 
目的是研究早期有计划地使用经肺热稀释(TPTD)和稳定血液循环的治疗措施对脓毒症临床结局的影响。这项队列研究涉及 132 名 SOFA >7 和血乳酸 >1.6 mmol/L 的腹腔败血症患者。56%的患者被诊断为脓毒性休克。53.8%的患者在重症监护早期开始出现TPTD。数据处理采用了逻辑回归和ROC分析法。早期使用有创监测(OR 2,3715,95 % CI 1,1107-5,0635,p=0,026,AUC 0.655)和输液量大于每天 43 毫升/千克(OR 1.0313,95 % CI 1.0073-1.0558,p=0.01,AUC 0.677)是腹腔败血症患者生存的预测因素。与第二组患者相比,使用 TPTD 的患者每日输液量增加(53.7 [38.1-63.5] vs 38.2 [29.9-47.2], ml/kg per day, p = 0.0001),使用肌力药物的频率更高(39.4 vs 16.4 %, p = 0.004),肌力评分水平更高(0 [0-4.7] vs 0 [0-0], p = 0.01)。去甲肾上腺素的处方频率(57.7 % vs 65.5 %,p = 0.376)和剂量(0.2 [0.1-0.4] vs 0.3 [0.2-0.4] μg/kg/min,p = 0.554)没有差异。第一组和第二组的二十八天死亡率分别为31%和50.8%(p = 0.022),住院死亡率分别为32.9%和54.0%(p = 0.014)。通过 SOFA > 7 分和乳酸血症 > 1.6 mmol/L 评估,TPTD 开始和输液量 > 43 mL/kg/天会增加腹腔败血症患者的生存几率,因此,28 天死亡率和住院死亡率降低了 1.6 倍。在这种临床情况下使用有创中枢血流动力学监测的同时,肌注药物的处方量增加了 2.4 倍,而去甲肾上腺素的使用强度保持不变。
{"title":"Role of invasive hemodynamics monitoring in sepsis intensive care","authors":"I. A. Kozlov, A. Ovezov, S. A. Rautbart","doi":"10.33667/2078-5631-2024-3-23-28","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-3-23-28","url":null,"abstract":"The objective was to study the effect of early planned use of transpulmonary thermodilution (TPTD) and therapeutic measures to stabilize blood circulation on the clinical outcome of sepsis.Materials and methods. The cohort study involved 132 patients with abdominal sepsis with SOFA >7 and blood lactate >1.6 mmol/L. Septic shock was diagnosed in 56 % of patients. TPTD in the early periods of intensive care was began in 53.8 % of patients. Logistic regression and ROC-analysis were used to process the data.Results. Early use of invasive monitoring (OR 2,3715, 95 % CI 1,1107–5,0635, p=0,026, AUC 0.655) and infusion volume >43 ml/kg per day (OR 1.0313, 95 % CI 1.0073–1.0558, p=0.01, AUC 0.677) were predictors of survival in patients with abdominal sepsis. The use of TPTD compared to patients of group II was accompanied by an increase in the daily infusion volume (53.7 [38.1–63.5] vs 38.2 [29.9–47.2], ml/kg per day, p = 0.0001), more frequent use of inotropic drugs (39.4 vs 16.4 %, p = 0.004), and higher level of the inotropic scale (0 [0–4.7] vs 0 [0–0], p = 0.01). There were no differences in the frequency of prescription (57.7 vs 65.5 %, p = 0.376) and dosages (0.2 [0.1–0.4] vs 0.3 [0.2–0.4] μg/kg/min, p = 0.554) of norepinephrine. Twenty-eight-day mortality in groups I and II was 31 and 50.8 % (p = 0.022), hospital mortality was 32.9 and 54.0 % (p = 0.014).Conclusion. When assessed by SOFA > 7 points and lactatemia > 1.6 mmol/L, the onset of TPTD and infusion volume > 43 mL/kg/day increase the likelihood of survival of patients with abdominal sepsis, as a result, 28-day and hospital mortality decrease by 1.6 times. The use of invasive monitoring of central hemodynamics in this clinical situation is accompanied by an increase in the prescription of inotropes by 2.4 times with an unchanged intensity of norepinephrine use. ","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141010746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term results of alternative antireflux surgery for gastroesophageal reflux disease and hiatal hernia 胃食管反流病和食管裂孔疝替代性抗反流手术的长期效果
Pub Date : 2024-05-06 DOI: 10.33667/2078-5631-2024-3-50-54
V. A. Baulin, A. A. Gulyaev, A. Baulin, O. A. Baulinа, L. A. Averyanova, V. A. Starodubtsev
The article is devoted to the use of a new method in open and laparoscopic surgery of gastroesophageal reflux disease and hiatal hernia. The essence of the technique is to fix the esophageal-gastric junction under the diaphragm with a combined tape of xenopericardium and propylene or propylene only. Comparative data on the results of Nissen operations in 126 patients and the new method in 258 patients are presented. The authors used an original comparative outcome assessment scale, which combines the main negative outcomes encountered after operations for gastroesophageal reflux disease and hiatal hernia, as well as Visick scale. The advantage of the new technique has been statistically reliably proven, where the absence of such severe complications as dysphagia, diarrhea, and stasis in its use is especially emphasized.
文章主要介绍了一种新方法在胃食管反流病和食管裂孔疝开腹和腹腔镜手术中的应用。该技术的精髓在于用异种心包和丙烯或仅丙烯的联合胶带将食管-胃交界处固定在横膈膜下。文中提供了 126 名患者的尼森手术结果与 258 名患者的新方法结果的比较数据。作者使用了一个原创的比较结果评估量表,该量表综合了胃食管反流病和食管裂孔疝手术后遇到的主要负面结果,以及 Visick 量表。新技术的优势在统计学上得到了可靠的证明,其中特别强调了在使用过程中不会出现吞咽困难、腹泻和淤血等严重并发症。
{"title":"Long-term results of alternative antireflux surgery for gastroesophageal reflux disease and hiatal hernia","authors":"V. A. Baulin, A. A. Gulyaev, A. Baulin, O. A. Baulinа, L. A. Averyanova, V. A. Starodubtsev","doi":"10.33667/2078-5631-2024-3-50-54","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-3-50-54","url":null,"abstract":"The article is devoted to the use of a new method in open and laparoscopic surgery of gastroesophageal reflux disease and hiatal hernia. The essence of the technique is to fix the esophageal-gastric junction under the diaphragm with a combined tape of xenopericardium and propylene or propylene only. Comparative data on the results of Nissen operations in 126 patients and the new method in 258 patients are presented. The authors used an original comparative outcome assessment scale, which combines the main negative outcomes encountered after operations for gastroesophageal reflux disease and hiatal hernia, as well as Visick scale. The advantage of the new technique has been statistically reliably proven, where the absence of such severe complications as dysphagia, diarrhea, and stasis in its use is especially emphasized.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141009584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alexander Sergeevich Puchkov’s activities as a member of the Russian Red Cross Society during the First World War 亚历山大-谢尔盖耶维奇-普奇科夫在第一次世界大战期间作为俄罗斯红十字会成员开展的活动
Pub Date : 2024-05-06 DOI: 10.33667/2078-5631-2024-3-29-35
A. N. Rozhenetskij, N. F. Plavunov, V. A. Kadyshev
The article is devoted to the activities of Alexander Sergeevich Puchkov as part of the Russian Red Cross Society, which during the First World War was one of the largest public organizations that provided assistance to wounded soldiers and officers in the theater of military operations and in the rear. The Red Cross appointed those responsible for all military sanitary, medical evacuation and organizational measures in this area of military operations: a special officer, a chief officer. The events of the period 1914–1918, which formed the professional qualities of the organizing physician A.S., are described. Puchkova, approaches and principles to providing medical care to the wounded in case of mass injuries and injuries in the performance of official duties of the special representative of the Russian Red Cross Society under the 2nd Army of the Western Front.
第一次世界大战期间,俄罗斯红十字会是为战区和后方受伤官兵提供援助的最大公共组织之一。红十字会在这一军事行动区任命了负责所有军事卫生、医疗后送和组织措施的人员:一名特别干事,一名主任干事。介绍了 1914-1918 年期间的事件,这些事件形成了组织医生 A.S. 的专业素质。普奇科娃,《西线第二军下属俄罗斯红十字会特别代表在执行公务中发生大规模伤亡时向伤员提供医疗救护的方法和原则》。
{"title":"Alexander Sergeevich Puchkov’s activities as a member of the Russian Red Cross Society during the First World War","authors":"A. N. Rozhenetskij, N. F. Plavunov, V. A. Kadyshev","doi":"10.33667/2078-5631-2024-3-29-35","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-3-29-35","url":null,"abstract":"The article is devoted to the activities of Alexander Sergeevich Puchkov as part of the Russian Red Cross Society, which during the First World War was one of the largest public organizations that provided assistance to wounded soldiers and officers in the theater of military operations and in the rear. The Red Cross appointed those responsible for all military sanitary, medical evacuation and organizational measures in this area of military operations: a special officer, a chief officer. The events of the period 1914–1918, which formed the professional qualities of the organizing physician A.S., are described. Puchkova, approaches and principles to providing medical care to the wounded in case of mass injuries and injuries in the performance of official duties of the special representative of the Russian Red Cross Society under the 2nd Army of the Western Front.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141006075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peculiarities of the ST-segment elevation myocardial infarction morphogenesis after mechanical restoration of epicardial blood flow without ECG signs of reperfusion 心外膜血流机械恢复后 ST 段抬高型心肌梗死形态发生的特殊性,心电图无再灌注迹象
Pub Date : 2024-05-06 DOI: 10.33667/2078-5631-2024-3-7-16
G. A. Nefedova, G. A. Gazaryan, G. P. Titova
The aim of the study was to investigate the peculiarities of STEMI morphogenesis after mechanical restoration of epicardial blood flow without ECG signs of reperfusion. The autopsy data of 44 patients with STEMI who died at different times after PCI performed within the first 12 hours (27 cases), or 12–24 hours (17 cases), without ECG signs of reperfusion after the intervention, were analyzed. The comparison group consisted of 85 deceased without reperfusion therapy (RT). Histological examination of the myocardium was performed at following time: within 12 hours, at 13–24 hours, 2–4 days, 5–8 days, 9–15 and 16–22 days. The most common cause of death was acute left ventricular failure (ALVF) both in the group of blood flow restoration without ECG signs of reperfusion, and in the group without RT: 85 % and 79 %, respectively. In each of the two groups the number of deaths occurred in the first 12 hours exceeded one third, half of the patients died in the subsequent 12 hours, two thirds of the deaths occurred within further 2–3 days. The rates of risk factors: older age, anterior and recurrent myocardial infarction, three-vessel lesion of the coronary artery, and a large infarction area were similar in the two groups. From the first hours after PCI, the infarction zone was characterized by hemorrhagic imbibition, numerous injuries of the microcirculatory bed, by the signs of blood flow restoration in damaged vessels appeared from days 2–4, early manifestations of repair from days 5–7. In the MI group without PCI, the hemorrhagic demarcation started on days from 3–4, coagulation necrosis prevailed in the microvascular bed, signs of repair appeared at a later date. Multiple spasms and thromboses in the microvasculature may have been a response to a blood pressure drop that accompanies an acute decrease in the left ventricle contractile function caused by a large infarction area and/or unresolved complications arising during the interventions per se. This mechanism explains the rapid progression of left ventricular failure, the most common cause of death after the interventions with achieving the epicardial blood flow without ECG signs of reperfusion. The revealed microcirculation disorders reflect the absence of myocardial reperfusion, which is more prognostically significant than the restoration of epicardial blood flow.
该研究旨在探讨在机械性恢复心外膜血流后,STEMI 形态发生的特殊性,而心电图却没有再灌注的迹象。研究分析了44例STEMI患者的尸检数据,这些患者在接受PCI治疗后的12小时内(27例)或12-24小时内(17例)死亡,且介入治疗后心电图无再灌注迹象。对比组包括85例未接受再灌注治疗(RT)的死亡病例。心肌组织学检查在以下时间进行:12 小时内、13-24 小时、2-4 天、5-8 天、9-15 天和 16-22 天。最常见的死亡原因是急性左心室衰竭(ALVF),在血流恢复但无心电图再灌注迹象的组别和未接受 RT 治疗的组别中分别为 85% 和 79%。在这两组患者中,在最初 12 小时内死亡的人数均超过三分之一,半数患者在随后的 12 小时内死亡,三分之二的死亡发生在随后的 2-3 天内。两组患者的危险因素:高龄、前部和复发性心肌梗死、冠状动脉三血管病变和大面积梗死的发生率相似。从 PCI 术后最初几小时开始,梗死区就出现出血浸润、微循环床大量损伤,第 2-4 天受损血管出现血流恢复迹象,第 5-7 天出现早期修复表现。在未进行 PCI 治疗的心肌梗死组,出血分界从第 3-4 天开始,微血管床普遍出现凝固性坏死,修复迹象出现的时间较晚。微血管多处痉挛和血栓形成可能是血压下降的反应,血压下降伴随着左心室收缩功能的急剧下降,而左心室收缩功能的急剧下降是由于梗死面积过大和/或介入治疗本身引起的并发症未得到解决所致。这一机制解释了左心室功能衰竭的快速发展,这也是介入治疗后最常见的死亡原因,介入治疗实现了心外膜血流,但心电图却没有再灌注的迹象。微循环障碍反映了心肌再灌注的缺失,这比心外膜血流的恢复对预后更有意义。
{"title":"Peculiarities of the ST-segment elevation myocardial infarction morphogenesis after mechanical restoration of epicardial blood flow without ECG signs of reperfusion","authors":"G. A. Nefedova, G. A. Gazaryan, G. P. Titova","doi":"10.33667/2078-5631-2024-3-7-16","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-3-7-16","url":null,"abstract":"The aim of the study was to investigate the peculiarities of STEMI morphogenesis after mechanical restoration of epicardial blood flow without ECG signs of reperfusion. The autopsy data of 44 patients with STEMI who died at different times after PCI performed within the first 12 hours (27 cases), or 12–24 hours (17 cases), without ECG signs of reperfusion after the intervention, were analyzed. The comparison group consisted of 85 deceased without reperfusion therapy (RT). Histological examination of the myocardium was performed at following time: within 12 hours, at 13–24 hours, 2–4 days, 5–8 days, 9–15 and 16–22 days. The most common cause of death was acute left ventricular failure (ALVF) both in the group of blood flow restoration without ECG signs of reperfusion, and in the group without RT: 85 % and 79 %, respectively. In each of the two groups the number of deaths occurred in the first 12 hours exceeded one third, half of the patients died in the subsequent 12 hours, two thirds of the deaths occurred within further 2–3 days. The rates of risk factors: older age, anterior and recurrent myocardial infarction, three-vessel lesion of the coronary artery, and a large infarction area were similar in the two groups. From the first hours after PCI, the infarction zone was characterized by hemorrhagic imbibition, numerous injuries of the microcirculatory bed, by the signs of blood flow restoration in damaged vessels appeared from days 2–4, early manifestations of repair from days 5–7. In the MI group without PCI, the hemorrhagic demarcation started on days from 3–4, coagulation necrosis prevailed in the microvascular bed, signs of repair appeared at a later date. Multiple spasms and thromboses in the microvasculature may have been a response to a blood pressure drop that accompanies an acute decrease in the left ventricle contractile function caused by a large infarction area and/or unresolved complications arising during the interventions per se. This mechanism explains the rapid progression of left ventricular failure, the most common cause of death after the interventions with achieving the epicardial blood flow without ECG signs of reperfusion. The revealed microcirculation disorders reflect the absence of myocardial reperfusion, which is more prognostically significant than the restoration of epicardial blood flow.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141007902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical alphabet
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1